Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved

Blocking tau appears to be just as fruitless as clearing amyloid buildup when it comes to helping Alzheimer’s disease (AD) patients. | Blocking tau appears to be just as fruitless as clearing amyloid buildup when it comes to helping Alzheimer’s disease patients.